PCA
GOSS icon

Pallas Capital Advisors’s Gossamer Bio GOSS Stock Holding History

Pallas Capital Advisors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12K Buy
12,879
+2,512
+24% +$701 ﹤0.01% 1034
2026
Q1 		$3.41K Buy
+10,367
New +$16.3K ﹤0.01% 862

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Pallas Capital Advisors's GOSS Position: Q2 2026 in Review

Pallas Capital Advisors increased its Gossamer Bio (GOSS) stake by 24% in Q2 2026, buying an estimated $701 and bringing the position to 12,879 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1034.

Pallas Capital Advisors first reported a position in GOSS in Q1 2026 and has held it in 2 quarters since. The position peaked at $3.41K in Q1 2026. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Pallas Capital Advisors held 12,879 shares of Gossamer Bio worth $2.12K as of Q2 2026.
  • Pallas Capital Advisors bought 2,512 Gossamer Bio shares in Q2 2026, an estimated $701.
  • Gossamer Bio made up ﹤0.01% of Pallas Capital Advisors's portfolio in Q2 2026, its #1034 holding.
  • Pallas Capital Advisors first reported a position in Gossamer Bio in Q1 2026 and has held it in 2 quarters since.
  • Pallas Capital Advisors's Gossamer Bio position peaked at $3.41K in Q1 2026.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Pallas Capital Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.